Iptacopan
- PMID: 39418405
- Bookshelf ID: NBK608175
Iptacopan
Excerpt
No information is available on the use of iptacopan during breastfeeding. The manufacturer states that breastfeeding should be discontinued during treatment and for 5 days after the final dose.
Similar articles
-
Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases.J Med Chem. 2020 Jun 11;63(11):5697-5722. doi: 10.1021/acs.jmedchem.9b01870. Epub 2020 Feb 19. J Med Chem. 2020. PMID: 32073845
-
Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria.Blood Rev. 2024 Jul;66:101210. doi: 10.1016/j.blre.2024.101210. Epub 2024 May 25. Blood Rev. 2024. PMID: 38811284 Review.
-
Ceritinib.2025 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2025 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999900 Free Books & Documents. Review.
-
Design and Rationale of the APPELHUS Phase 3 Open-Label Study of Factor B Inhibitor Iptacopan for Atypical Hemolytic Uremic Syndrome.Kidney Int Rep. 2023 Apr 29;8(7):1332-1341. doi: 10.1016/j.ekir.2023.04.029. eCollection 2023 Jul. Kidney Int Rep. 2023. PMID: 37441479 Free PMC article.
-
Brigatinib.2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999976 Free Books & Documents. Review.
Publication types
LinkOut - more resources
Full Text Sources